Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · IEX Real-Time Price · USD

1.430

+0.010 (0.70%)

At close: Apr 25, 2024, 4:00 PM

1.411

-0.019 (-1.33%)

After-hours: Apr 25, 2024, 5:18 PM EDT

Spero Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	22.81	-46.42	-89.76	-78.28	-60.93	-41.66	-46.1	-29.93	-13.43
Depreciation & Amortization	0.37	0.87	0.65	0.76	0.75	0.41	0.36	0.28	0.01
Share-Based Compensation	7.93	9.12	9.43	4.89	3.78	2.75	1.43	0.18	0.02
Other Operating Activities	-64.1	28.69	15.33	-13.24	6.38	-1.12	-2.16	-3.93	3.51
Operating Cash Flow	-33	-7.73	-64.35	-85.87	-50.02	-39.63	-39.11	-28.96	-9.61
Capital Expenditures	0	0	0	0	-0.31	-2.44	-0.03	-0.83	-0.23
Change in Investments	0	33.81	7.63	10.63	29.84	-80.72	0	0	0
Other Investing Activities	-	-	0.04	-0.16	-	-	-	-	-
Investing Cash Flow	0	33.81	7.67	10.47	29.53	-83.16	-0.03	-0.83	-0.23
Share Issuance / Repurchase	0.22	24.93	36.82	80.85	16.3	70.84	74.18	0	0
Debt Issued / Paid	0	-54.49	0	0	0	0	0	0	0
Other Financing Activities	-	-	47.23	50.03	-0.16	-1.31	41.94	34.41	15.28
Financing Cash Flow	0.22	-29.55	84.05	130.88	16.14	69.52	116.11	34.41	15.28
Net Cash Flow	-32.77	-3.48	27.38	55.48	-4.35	-53.26	76.97	4.62	5.44
Free Cash Flow	-33	-7.73	-64.35	-85.87	-50.33	-42.06	-39.14	-29.79	-9.84
Free Cash Flow Margin	-31.79%	-14.45%	-352.47%	-920.39%	-277.37%	-1060.54%	-1977.67%	-8892.24%	-
Free Cash Flow Per Share	-0.63	-0.21	-2.08	-3.84	-2.77	-2.63	-15.13	-95.43	-38.92

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).